Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.90 +16.88%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
